Jan 25, 2021 | Letters Supported, Step Therapy
The American Autoimmune Related Diseases Association (AARDA), other patient advocates and providers understand that UnitedHealthcare intends to move Remicade from preferred to non-preferred coverage in February 2021. This abrupt change by the plan could be disruptive...
Aug 25, 2020 | Copay Assistance, COVID-19, Letters Supported
On behalf of the undersigned organizations and over 45 million persons covered by Medicare Part D and their family caregivers, we urge you to rescind the current ban on the use of copay cards in the Medicare Part D program at least through the current Novel...
Aug 12, 2020 | Copay Assistance, Letters Supported
The undersigned organizations, on behalf of tens of millions of Americans with serious illnesses, chronic conditions, and disabilities, are submitting this formal comment pertaining to your recent Notice of Proposed Rule Making. While we appreciate the Centers for...
Jul 7, 2020 | Federal Issues, Letters Supported, Out of Pocket Costs
Throughout the country, millions of patients rely on cost-sharing assistance programs, which reduce patient out-of-pocket costs for prescription medications. For many individuals, these cost reductions are significant, allowing them to afford the medications necessary...
Jul 6, 2020 | Copay Assistance, Letters Supported, State Issues
Co-pay assistance helps to offset the cost sharing imposed by insurers, and allows patients to adhere to their medically needed treatments. They are often the only way patients can access critical medications for a wide array of disease states including, but not...
Jun 19, 2020 | Health Insurance, Letters Supported
As you continue the critically important work of supporting our patients and frontline workers during the COVID-19 crisis, we are writing to urge you to include in the next stimulus package protections for the health care coverage of employees and employers impacted...
